Keywords: nicox, initiates, final, ph, iii, naproxcinod, trial

NicOx initiates final Ph III naproxcinod trial

Article | 09 July 2007

Print This

French drugmaker NicOx SA has initiated the third pivotal Phase III trial of naproxcinod in patients with osteoarthritis of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in